オープン アクセスを義務付けられた論文 - Zhigang Wang詳細
一般には非公開: 13 件
A photocaged, water-oxidizing, and nucleolus-targeted Pt (IV) complex with a distinct anticancer mechanism
Z Deng, N Wang, Y Liu, Z Xu, Z Wang, TC Lau, G Zhu
Journal of the American Chemical Society 142 (17), 7803-7812, 2020
委任: National Natural Science Foundation of China, Research Grants Council, Hong Kong
Recent advances in the synthesis, stability, and activation of platinum (IV) anticancer prodrugs
Z Xu, Z Wang, Z Deng, G Zhu
Coordination Chemistry Reviews 442, 213991, 2021
委任: National Natural Science Foundation of China, Research Grants Council, Hong Kong
A platinum (IV) anticancer prodrug targeting nucleotide excision repair to overcome cisplatin resistance
Z Wang, Z Xu, G Zhu
Angewandte Chemie International Edition 55 (50), 15564-15568, 2016
委任: National Natural Science Foundation of China
Sulfonic-Group-Grafted Ti3C2Tx MXene: A Silver Bullet to Settle the Instability of Polyaniline toward High-Performance Zn-Ion Batteries
Y Liu, Z Dai, W Zhang, Y Jiang, J Peng, D Wu, B Chen, W Wei, X Chen, ...
ACS nano 15 (5), 9065-9075, 2021
委任: National Natural Science Foundation of China
Heterodinuclear Pt (iv)–Ru (ii) anticancer prodrugs to combat both drug resistance and tumor metastasis
L Ma, R Ma, Z Wang, SM Yiu, G Zhu
Chemical Communications 52 (71), 10735-10738, 2016
委任: National Natural Science Foundation of China
Novel Pt-loaded layered double hydroxide nanoparticles for efficient and cancer-cell specific delivery of a cisplatin prodrug
R Ma, Z Wang, L Yan, X Chen, G Zhu
Journal of Materials Chemistry B 2 (30), 4868-4875, 2014
委任: National Natural Science Foundation of China
Efficient co-delivery of a Pt (iv) prodrug and a p53 activator to enhance the anticancer activity of cisplatin
R Ma, Y Wang, L Yan, L Ma, Z Wang, HC Chan, SK Chiu, X Chen, G Zhu
Chemical Communications 51 (37), 7859-7862, 2015
委任: National Natural Science Foundation of China
Enhancing Circulation and Tumor Accumulation of Carboplatin via an Erythrocyte‐Anchored Prodrug Strategy
H Yao, Z Wang, N Wang, Z Deng, G Liu, J Zhou, S Chen, J Shi, G Zhu
Angewandte Chemie 134 (25), e202203838, 2022
委任: National Natural Science Foundation of China, Research Grants Council, Hong Kong
Mono-and di-bromo platinum (IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity
Z Xu, Z Wang, SM Yiu, G Zhu
Dalton Transactions 44 (46), 19918-19926, 2015
委任: National Natural Science Foundation of China
A monofunctional platinum (II)-based anticancer agent from a salicylanilide derivative: Synthesis, antiproliferative activity, and transcription inhibition
B Wang, Z Wang, F Ai, WK Tang, G Zhu
Journal of inorganic biochemistry 142, 118-125, 2015
委任: National Natural Science Foundation of China
Discovery of a far-red carbazole-benzoindolium fluorescent ligand that selectively targets mitochondrial DNA and suppresses breast cancer growth
Z Wang, J Zhou, L Lin, MH Hu
European Journal of Medicinal Chemistry 264, 116046, 2024
委任: National Natural Science Foundation of China
Highly photoactive Ir (iii)–Pt (iv) heterometallic conjugates for anticancer therapy
W Hu, R Liu, K Zheng, Z Wang
Chemical Communications 60 (4), 388-391, 2024
委任: National Natural Science Foundation of China
Ligand substitution reactions afford oxaliplatin-based platinum (IV) complexes bearing axial alkoxido ligands
Z Xu, L Lin, B Fu, FP Huang, Q Zhou, G Zhu, Z Wang
Inorganic Chemistry Frontiers 10 (20), 6058-6066, 2023
委任: National Natural Science Foundation of China
一般公開: 14 件
Poking cells for efficient vector-free intracellular delivery
Y Wang, Y Yang, L Yan, SY Kwok, W Li, Z Wang, X Zhu, G Zhu, W Zhang, ...
Nature communications 5 (1), 4466, 2014
委任: National Natural Science Foundation of China
Phorbiplatin, a highly potent Pt (IV) antitumor prodrug that can be controllably activated by red light
Z Wang, N Wang, SC Cheng, K Xu, Z Deng, S Chen, Z Xu, K Xie, MK Tse, ...
Chem 5 (12), 3151-3165, 2019
委任: National Natural Science Foundation of China, Research Grants Council, Hong Kong
A cisplatin‐loaded immunochemotherapeutic nanohybrid bearing immune checkpoint inhibitors for enhanced cervical cancer therapy
N Wang, Z Wang, Z Xu, X Chen, G Zhu
Angewandte Chemie International Edition 57 (13), 3426-3430, 2018
委任: National Natural Science Foundation of China
Combined chemotherapy and photodynamic therapy using a nanohybrid based on layered double hydroxides to conquer cisplatin resistance
Z Wang, R Ma, L Yan, X Chen, G Zhu
Chemical communications 51 (58), 11587-11590, 2015
委任: National Natural Science Foundation of China
Size controllable and surface tunable zeolitic imidazolate framework-8–poly (acrylic acid sodium salt) nanocomposites for pH responsive drug release and enhanced in vivo cancer …
L Yan, X Chen, Z Wang, X Zhang, X Zhu, M Zhou, W Chen, L Huang, ...
ACS applied materials & interfaces 9 (38), 32990-33000, 2017
委任: Research Grants Council, Hong Kong
An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance
F Ai, T Sun, Z Xu, Z Wang, W Kong, MW To, F Wang, G Zhu
Dalton Transactions 45 (33), 13052-13060, 2016
委任: National Natural Science Foundation of China
Chemoresistant lung cancer stem cells display high DNA repair capability to remove cisplatin‐induced DNA damage
WK Yu, Z Wang, CC Fong, D Liu, TC Yip, SK Au, G Zhu, M Yang
British Journal of Pharmacology 174 (4), 302-313, 2017
委任: National Natural Science Foundation of China, Research Grants Council, Hong Kong
公開と助成金に関する情報は、コンピュータ プログラムによって自動的に決定されます